Literature DB >> 5047049

The oral toxicity of clindamycin in laboratory animals.

J E Gray, R N Weaver, J A Bollert, E S Feenstra.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5047049     DOI： 10.1016/0041-008x(72)90008-7

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  6 in total

1.  A novel dextran polymer hydrogel local antimicrobial therapy in dogs: A pilot study.

Authors:  Travis P Reed; Leslie A Thomas; F Robert Weeren; Jeffrey D Ruth; Brendan B Anders
Journal:  Can Vet J       Date:  2016-02       Impact factor: 1.008

2.  Clindamycin bioavailability from clindamycin-2-palmitate and clindamycin-2-hexadecylcarbonate in man.

Authors:  A A Forist; R M DeHaan; C M Metzler
Journal:  J Pharmacokinet Biopharm       Date:  1973-04

3.  Protection from doxorubicin-induced nephrotoxicity by clindamycin: novel antioxidant, anti-inflammatory and anti-apoptotic roles.

Authors:  Kamilia M Ibrahim; Eman M Mantawy; Mona M Elanany; Hend S Abdelgawad; Nuha M Khalifa; Rada H Hussien; Nermeen N El-Agroudy; Ebtehal El-Demerdash
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-18       Impact factor: 3.000

4.  Clindamycin-associated colitis.

Authors:  J L Unger; W E Penka; C Lyford
Journal:  Am J Dig Dis       Date:  1975-03

5.  Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations.

Authors:  Jean D Brender; Martha M Werler; Mayura U Shinde; Ann M Vuong; Katherine E Kelley; John C Huber; Joseph R Sharkey; John S Griesenbeck; Paul A Romitti; Sadia Malik; Lucina Suarez; Peter H Langlois; Mark A Canfield
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-08-18

6.  Assessment of hepatotoxic potential.

Authors:  J E Gray
Journal:  Environ Health Perspect       Date:  1976-06       Impact factor: 9.031
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.